From: Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study
Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
OR (95% C.I.) | P-value | BSI model OR (95% C.I.) | P-value | FACED model OR (95% C.I.) | P-value | |
Age | 1.07 (1.04–1.08) | <0.001 | 1.01 (0.99–1.04) | 0.270 | 1.03 (1.01–1.07) | 0.021 |
Male | 2.68 (1.57–4.58) | <0.001 | 1.27 (0.57–2.82) | 0.559 | 0.16 (0.53–2.54) | 0.702 |
Pneumococcal vaccine | 0.49 (0.29–0.80) | 0.005 | 0.37 (0.19–0.70) | 0.003 | 0.40 (0.21–0.74) | 0.004 |
Diabetes Mellitus | 3.64 (1.55–8.57) | 0.003 | 1.62 (0.60–4.76) | 0.355 | 1.57 (0.59–4.55) | 0.380 |
Myocardial infarction | 5.53 (1.24–24.60) | 0.025 | 0.78 (0.14–6.92) | 0.794 | 0.72 (0.13–6.06) | 0.727 |
Heart failure | 7.89 (2.34–26.54) | 0.001 | 6.31 (1.55–43.07) | 0.023 | 5.47 (1.36–37.23) | 0.035 |
COPD | 4.18 (2.06–8.47) | <0.001 | 2.06 (0.79–5.63) | 0.145 | 2.42 (0.93–6.59) | 0.074 |
Previous MDR colonization | 2.27 (0.94–5.50) | 0.070 | 0.97 (0.32–3.10) | 0.956 | 1.16 (0.40–3.61) | 0.791 |
Long-acting anticholinergic | 2.54 (1.53–4.22) | <0.001 | 1.48 (0.74–2.92) | 0.262 | 1.69 (0.87–3.30) | 0.120 |
Proton pump inhibitor | 4.78 (2.77–8.24) | <0.001 | 2.64 (1.35–5.26) | 0.005 | 2.85 (1.48–5.59) | 0.002 |
Chronic oxygen therapy | 4.52 (1.52–13.39) | 0.007 | 1.82 (0.46–9.47) | 0.427 | 2.73 (0.70–14.05) | 0.179 |
Previous hospitalization due to BE at any time | 3.25 (1.93–5.46) | <0.001 | – | – | 2.63 (1.36–5.17) | 0.005 |
Previous history of pneumonia | 1.81 (1.095–3.00) | 0.021 | 1.55 (0.81–2.99) | 0.185 | 1.41 (0.73–2.75) | 0.307 |
FACED | 5.22 (2.97–9.20) | <0.001 | – | – | 0.97 (0.78–1.22) | 0.810 |
BSI | 13.79 (6.53–29.13) | <0.001 | 1.20 (1.09–1.32) | <0.001 | – | – |